Japan Metagenomic Sequencing Market to hit US$ 270 Million by 2033 | Top Companies - Thermo Fisher Scientific Inc., Qiagen N.V., BGI Group

Leander, Texas and Tokyo, Japan - Dec.29.2025
As per DataM intelligence research report" Metagenomic Sequencing Market reached US$ 2.31 billion in 2024 and is expected to reach US$ 9.25 billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033." Microbiome research and pathogen detection needs are fueling metagenomic sequencing adoption.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/metagenomic-sequencing-market?prasad

Japan: Recent Industry Developments

✅ In December 2025, Oxford Nanopore Technologies Japan partnered with a university to track hospital infections. The project uses portable sequencers to trace bacterial outbreaks in real-time. It enhances infection control in Japanese medical facilities.

✅ In November 2025, A Japanese startup launched a "Gut Flora" testing service using shotgun metagenomics. The service offers deep insights into functional pathways of the microbiome. It provides a premium health checkup option for Japanese consumers.

✅ In October 2025, The National Institute of Genetics established a new metagenomic database for Asian populations. The database collects microbiome data specific to Japanese and Asian diets/genetics. It supports localized medical research and drug development.

✅ In September 2025, Suntory Global Innovation Center used metagenomics to analyze soil health in vineyards. The research links soil microbial diversity to wine quality. It applies advanced genomics to Japan's agriculture and beverage sectors.

United States: Recent Industry Developments

✅ In November 2025, Illumina launched a new "Metagenomics Module" for its NovaSeq X series. The workflow simplifies the detection of unknown pathogens in clinical samples. It advances the capability of U.S. labs to diagnose rare infectious diseases.

✅ In October 2025, PacBio introduced long-read sequencing kits optimized for microbiome analysis. The technology provides complete genome assembly of bacteria in complex samples. It improves the resolution of microbiome research in the U.S.

✅ In September 2025, IDbyDNA (Illumina) released a cloud platform for metagenomic data interpretation. The software identifies thousands of pathogens and antimicrobial resistance genes instantly. It democratizes advanced diagnostics for U.S. hospital networks.

✅ In August 2025, The CDC expanded its wastewater surveillance program using metagenomic sequencing. The program tracks emerging variants and novel viruses in community sewage. It strengthens U.S. public health monitoring infrastructure.

Metagenomic Sequencing Market: Drivers
The metagenomic sequencing market is growing rapidly due to increasing demand for comprehensive analysis of microbial communities in human health, agriculture, and environmental research. Advances in next-generation sequencing (NGS) technologies enable high-throughput, cost-effective, and accurate microbial profiling. Applications in microbiome research, disease diagnostics, and personalized medicine are driving adoption. Regulatory and research funding support large-scale sequencing projects and innovation. Collaborative initiatives between academic institutions, biotech companies, and healthcare organizations accelerate development and commercialization. Rising awareness of the role of microbes in health and disease further fuels market growth. Technological innovations in bioinformatics, data analysis, and sample preparation enhance efficiency and usability.

The growing integration of metagenomics with artificial intelligence and machine learning improves predictive capabilities and data interpretation. Expansion in agricultural and environmental applications, including soil health and bioremediation, supports broader market adoption. Strategic partnerships between sequencing service providers and research labs enhance accessibility. Rising focus on precision medicine, microbiome therapeutics, and personalized nutrition strengthens demand. Continuous innovation in sequencing platforms, cost reduction, and automation promotes global market growth. Metagenomic sequencing is becoming an essential tool in research, diagnostics, and biotechnology with long-term expansion potential.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/metagenomic-sequencing-market?prasad

Metagenomic Sequencing Market: Major Players
Thermo Fisher Scientific Inc., Qiagen N.V., BGI Group, Merck KGaA, Eurofins Scientific, Illumina, Inc., Oxford Nanopore Technologies Ltd., F. Hoffmann-La Roche Ltd., Zymo Research Corporation, and PacBio, among others.

Segment Covered in the Metagenomic Sequencing Market:
By Product & Service
The market is segmented into Sequencing Platforms 40%, Reagents & Kits 30%, Software & Bioinformatics Tools 15%, and Services 15%, with sequencing platforms dominating due to widespread adoption for microbial diversity analysis, pathogen identification, and clinical diagnostics. Reagents and kits support sample preparation, library construction, and targeted sequencing. Software and bioinformatics tools are growing rapidly due to increasing data analysis requirements. Outsourced sequencing services are gaining traction among small laboratories and research institutions.

By Technology
Technologies include Next-Generation Sequencing (NGS) 60%, Third-Generation Sequencing (TGS) 25%, and Others 15%, with NGS dominating due to high throughput, accuracy, and cost-effectiveness for metagenomic studies. TGS technologies are gaining adoption for long-read sequencing, improved genome assembly, and complex microbial community analysis. Rapid technological advancements support market growth.

By Application
Applications include Clinical Diagnostics 35%, Environmental & Microbiome Research 30%, Food & Agriculture 20%, and Others 15%, with clinical diagnostics dominating due to increasing use in infectious disease detection, antimicrobial resistance studies, and precision medicine. Environmental and microbiome research applications are growing with increasing interest in soil, marine, and human microbiome studies. Food and agriculture applications include quality control, pathogen detection, and crop microbiome research.

Regional Analysis
North America - 40% Share
North America leads with 40% share, driven by strong presence of sequencing technology providers, high R&D investment, and increasing adoption in clinical and microbiome research. NGS platforms and sequencing reagents dominate regional demand. Clinical diagnostics and environmental research applications drive market growth.

Europe - 25% Share
Europe accounts for 25% share, supported by growing academic research, pharmaceutical R&D, and government-funded microbiome projects in Germany, France, and the UK. Sequencing platforms, reagents, and bioinformatics tools are widely used. Environmental and clinical applications lead demand. Regulatory support and precision medicine initiatives drive growth.

Asia Pacific - 20% Share
Asia Pacific holds 20% share, driven by expanding genomics research, increasing sequencing infrastructure, and growing biotechnology and pharmaceutical sectors in China, Japan, and India. NGS platforms dominate. Clinical diagnostics and environmental research applications are primary growth drivers. Rising R&D investment and collaborations support market expansion.

Latin America - 10% Share
Latin America records 10% share, supported by emerging genomics research initiatives, expanding laboratory infrastructure, and increasing clinical diagnostics adoption in Brazil and Mexico. NGS platforms and reagents dominate. Environmental and food microbiome studies drive steady market growth.

Middle East & Africa - 5% Share
Middle East & Africa account for 5% share, driven by increasing investment in genomic research, clinical diagnostics, and environmental studies. Sequencing platforms and reagents dominate regional demand. Government-supported projects and academic research drive gradual market adoption.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=metagenomic-sequencing-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.